The Center research base is focused on five major themes: 1. Cellular and molecular biology of the hepatocyte. 2. Hepatic transport mechanisms. 3.. Hepatic metabolic functions. 4. Studies on splanchnic hemodynamics and 5. Clinical studies of hepatic disorders. Research activities of the Center are broad and range from fundamental studies of the biology of the hepatocyte to clinical therapeutic trials of immediate clinical relevance to the diagnosis and treatment of chronic human liver disease. The principal goals of the Center are to: 1) stimulate multidisciplinary activities. 2) to provide a rich training environment. 3) to foster National and International collaborations. 4) to officially organize time consuming, more costly techniques and procedures, and Core facilities for multiple investigator use. 5) to stimulate basic scientists to become involved in one or more of the Center's research interests. 6) to capitalize on important new research opportunities through pilot feasibility projects, and 7) to create an institutional environment that will greatly amplify progress and answer problems in this important area of Digestive Disease. To carry out these goals, the Center is organized into six core facilities of 1) Administrative Core, 2) Hepatocyte Isolation and Cell Culture Core, 3) Liver Vascular Perfusion Core, 4) Molecular Membrane Biology Core, 5) Morphology Core, and 6) Clinical Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034989-11
Application #
2139451
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1984-09-30
Project End
1999-08-31
Budget Start
1994-09-15
Budget End
1995-08-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Fiorotto, Romina; Amenduni, Mariangela; Mariotti, Valeria et al. (2018) Src kinase inhibition reduces inflammatory and cytoskeletal changes in ?F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 67:972-988
Sari, Sinan; Dalgic, Buket; Muehlenbachs, Atis et al. (2018) Prototheca zopfii Colitis in Inherited CARD9 Deficiency. J Infect Dis 218:485-489
Yu, Dongke; Cai, Shi-Ying; Mennone, Albert et al. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int 38:1128-1138
Garcia-Tsao, Guadalupe (2018) Regression of HCV cirrhosis: Time will tell. Hepatology 67:1651-1653
Hung, Adelina; Garcia-Tsao, Guadalupe (2018) Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int 38:1437-1441
Kaffe, Eleanna; Fiorotto, Romina; Pellegrino, Francesca et al. (2018) ?-Catenin and interleukin-1?-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 67:1903-1919
Goldberg, David S; Levy, Cynthia; Yimam, Kidist et al. (2018) Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium. Clin Gastroenterol Hepatol 16:591-593
Cadamuro, Massimiliano; Stecca, Tommaso; Brivio, Simone et al. (2018) The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis 1864:1435-1443
Besse, Whitney; Choi, Jungmin; Ahram, Dina et al. (2018) A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family. Hum Mutat 39:378-382
Strazzabosco, Mario; Fiorotto, Romina; Cadamuro, Massimiliano et al. (2018) Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochim Biophys Acta Mol Basis Dis 1864:1374-1379

Showing the most recent 10 out of 763 publications